MedTrace Logo

Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda

NCT07562399 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2026-05-20

No results posted yet for this study

Summary

This study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast cancer in Rwanda. The intervention includes educational, behavioral, and reminder components, and will be assessed for feasibility and impact on medication adherence.

Conditions

Interventions

BEHAVIORAL

Educational video

One-time educational video

BEHAVIORAL

Symptom monitoring card

Symptom monitoring card

BEHAVIORAL

Text reminders

Weekly one-way text reminders

Sponsors & Collaborators

Principal Investigators

  • Temidayo Fadelu, MD · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-20
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • United States
  • Rwanda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07562399 on ClinicalTrials.gov